rs2227284 — IL4 IL4 T+2979G

IL4 T+2979G — The Th2 Dimmer Switch in Intron 3

Interleukin-4 is the master architect of the Th2 immune response. It drives B cells to class-switch from IgM to IgE¹¹ IgE
Immunoglobulin E — the antibody class responsible for allergic reactions; IgE binds mast cells and basophils, which explode with histamine upon allergen encounter, steers naive T cells toward the Th2 fate that underlies atopic disease, and suppresses the Th1 arm of immunity that fights intracellular pathogens. A variant in intron 3 of the IL4 gene — rs2227284, historically designated T+2979G — alters the regulatory machinery controlling IL-4 transcription. The T allele is associated with elevated susceptibility to asthma, allergic rhinitis, and severe bacterial infections; the G allele with relative protection across multiple independent study populations.

The Mechanism

rs2227284 sits within intron 3 of IL4 on chromosome 5q31.1. It does not change the IL-4 protein sequence. Instead, it lies in a region that influences IL-4 transcriptional regulation — a stretch of intronic sequence long suspected to be part of the gene's locus control region, the same genomic neighborhood that contains the IL4 intron 3 variable number tandem repeat (VNTR)²² variable number tandem repeat (VNTR)
A repeated DNA motif (RP1 repeat) whose copy number varies between individuals and has been associated with IL-4 production levels; rs2227284 is in strong linkage disequilibrium with the VNTR haplotype in many populations. The strongest statistical link to phenotype is through IgE regulation: a Polish pediatric cohort³³ Polish pediatric cohort
177 asthmatic children versus 194 controls, examining IL4, IL4R, and IL13 variants found that rs2227284 had the most significant association with total IgE levels of any IL4 variant tested (p=0.00047) — a compelling fingerprint that this intronic position modulates IL-4 transcriptional output rather than protein function.

The directionality across populations is consistent: the T allele (GRCh38 plus-strand reference, but the rarer allele in Europeans at ~29% frequency) associates with elevated atopic disease risk and higher IgE, while the G allele (major in Europeans at ~71%) is associated with lower risk. Ethnically, G allele frequency varies enormously — ~71% in Europeans, ~64% in South Asians, ~40% globally, ~16% in East Asians and ~9% in Africans — which explains why directional effects can differ across study populations.

The Evidence

In a study of 393 Japanese women with rhinoconjunctivitis and 703 controls⁴⁴ 393 Japanese women with rhinoconjunctivitis and 703 controls
Kyushu Okinawa Maternal and Child Health Study cohort, using ISAAC criteria for rhinoconjunctivitis definition, the GG genotype at rs2227284 was significantly inversely associated with rhinoconjunctivitis compared with TT (adjusted OR 0.60, 95% CI 0.37–0.98). The protective effect was confined to never-smokers — an important interaction suggesting that smoking, which independently dysregulates IL-4 signaling, can override the genotype's protective direction.

In 503 Chinese Han children with allergic rhinitis and 393 controls⁵⁵ 503 Chinese Han children with allergic rhinitis and 393 controls
a GWAS-loci validation study examining 16 candidate SNPs in childhood AR, the TG genotype was associated with a 0.65-fold decreased risk of AR compared with TT. A C-G-C haplotype spanning rs2243250–rs2227284–rs2243290 was protective, placing the G allele as part of the low-risk regulatory haplotype.

Among 214 Pakistani patients (108 asthma, 106 allergic rhinitis) versus 120 healthy controls⁶⁶ 214 Pakistani patients (108 asthma, 106 allergic rhinitis) versus 120 healthy controls
cross-sectional study examining three IL4 intronic SNPs, rs2227284 showed significant associations with both asthma (chi-square 22.51, p<0.001) and allergic rhinitis (chi-square 57.6, p<0.001) — the strongest p-values among all three IL4 variants studied. A Chinese pediatric study⁷⁷ Chinese pediatric study
392 asthmatic children and 849 controls examining both IL-2 and IL-4 polymorphisms confirmed that rs2227284 was associated with reduced asthma risk in both heterozygotes (p=0.026) and G-allele homozygotes (p=0.001).

Beyond atopy, the variant's immunological reach extends to infection severity. A study of 57 adult pneumococcal pneumonia patients and 280 controls⁸⁸ study of 57 adult pneumococcal pneumonia patients and 280 controls
focused on host genetics and P-CAP susceptibility and severity found IL4 rs2227284 associated with severe pneumococcal community-acquired pneumonia (OR 2.17, p=0.04), consistent with the T allele's effect on Th2 immune polarization impairing Th1-dependent antibacterial clearance. A 2024 Chinese RA study (n=986) additionally found the G allele protective against rheumatoid arthritis development, adding autoimmune susceptibility to the variant's phenotypic repertoire.

Practical Actions

For TT homozygotes — who carry both T alleles and sit at highest risk — the primary value of knowing this genotype is heightened awareness of atopic disease progression. The T allele's clearest clinical signal is in individuals who are already atopically sensitized: if you have eczema, allergic rhinitis, or food allergy, the elevated IL-4 regulatory output at the rs2227284 locus amplifies your risk of asthma development (the atopic march). Monitoring total IgE and seeking early allergist evaluation are the most direct responses.

The smoking interaction documented in the rhinoconjunctivitis data is clinically significant for TG heterozygotes: the G allele's protective effect was abolished in ever-smokers. This means the partial protection the G allele confers is contingent on avoiding tobacco exposure.

For all T-allele carriers, antihistamines and corticosteroid nasal sprays treat symptoms; allergen immunotherapy addresses the underlying Th2-skewing mechanism by redirecting the immune response toward Th1/Treg tolerance and, in doing so, directly opposes the mechanism this variant amplifies.

Interactions

rs2243250 (C-589T, promoter), rs2070874 (C-33T), and rs2243290 are the other major IL4 SNPs studied alongside rs2227284. They form haplotypes that collectively determine IL-4 expression level; rs2243250 is typically the strongest individual signal in promoter-focused studies. rs2227284 and rs2243250 travel together in the protective C-G haplotype (rs2243250 C + rs2227284 G) documented in East Asian cohorts.

rs7130588 (LRRC32/11q13.5) and rs1805011 (IL4Rα I50V) are pathway partners — LRRC32 controls Treg-mediated TGF-β tolerance, and IL4Rα rs1805011 controls IL-4 receptor signaling downstream of IL-4 binding. Carrying risk alleles at multiple nodes of the IL-4/Th2 axis (IL4 production at rs2227284, receptor sensitivity at rs1805011, and Treg tolerance at rs7130588) may cumulatively define the highest-risk atopic phenotype, though formal compound analyses of this exact combination remain unpublished.